[Expulsion of arrested pregnancy product in the 2d trimester using a prostaglandin E1 analog administered intravaginally. Apropos of 12 cases].
In this paper the authors report on the use of a prostaglandin E1 analog to expel fetuses stillborn in utero in the second trimester of pregnancy. Results of this clinical series make it possible to conclude on the efficacy of this agent and its simple utilization. Minor inconsequential side-effect observed coincide with the total absence of any complications.
Lehair
J
J
Service de Gynécologie-Obstétrique, CHR Notre Dame du Bon Secours, Metz.
Lemarie
P
P
Helleringer
M
M
Manini
P
P
D000019:Abortifacient Agents / Q000008:administration & dosage*; D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage*; D000028:Abortion, Induced; D000282:Administration, Intravaginal; D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005260:Female; D005313:Fetal Death; D006801:Humans; D011247:Pregnancy; D011459:Prostaglandins E, Synthetic / Q000008:administration & dosage*
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D011459:Prostaglandins E, Synthetic; C021182:gemeprost; D000527:Alprostadil
Expulsion de grossesses arrêtées au deuxiéme trimestre à l'aide d'un analogue de la prostaglandine E1 appliqué par voie vaginale. A propos de douze cas.